Revelation Biosciences, Inc., a Life Sciences Company Developing Therapeutics and Diagnostics for Respiratory Viral Infections, Including COVID-19, to Become Publicly Traded Through a Merger with Petra Acquisition, Inc.

Revelation Biosciences, Inc., a clinical-stage life sciences company focused on the development of immunologic‑based therapies for the prevention and treatment of disease, and Petra Acquisition, Inc., today announced they have entered into a definitive merger agreement for a business combination that will result in Revelation becoming a publicly-traded company.

UK’s Cazoo will list on the NYSE by way of a SPAC, valuing it at $7B and raising $1.6B

Cazoo, the UK used-car sales portal that has been on a major fundraising tear in the last year, will be next company to pursue more growth by way of a SPAC: the company today announced that it will list on the NYSE by way of a business combination with AJAX I, a special purpose acquisition vehicle founded by hedge fund supremo Dan Och in partnership with Glenn Fuhrman and others.